FDA Officials Show Support for Risk-Based CAPA Strategy By Sam | October 9, 2017 FDA officials welcomed a risk-based approach to CAPA systems during a session at 2017 RAPS Regulatory Convergence, but cautioned that each CAPA investigation is unique. Source: The GMP Letter Posted in The GMP Letter